0.6499	2.3975	OMIM:614492	#614492 PSEUDOHYPOALDOSTERONISM, TYPE IIC; PHA2C	WNK1	65125
0.6499	2.3975	OMIM:614495	#614495 PSEUDOHYPOALDOSTERONISM, TYPE IID; PHA2D;;FAMILIAL HYPERKALEMIC HYPERTENSION; FHHT	KLHL3	26249
0.6499	2.3975	OMIM:614491	#614491 PSEUDOHYPOALDOSTERONISM, TYPE IIB; PHA2B	WNK4	65266
0.6499	2.3975	OMIM:614496	#614496 PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	CUL3	8452
0.6499	2.2494	OMIM:261590	PHENFORMIN 4-HYDROXYLATION		
0.6499	1.8288	OMIM:145260	PSEUDOHYPOALDOSTERONISM, TYPE II		
0.6499	1.6878	OMIM:145600	#145600 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1;;MHS;;HYPERTHERMIA OF ANESTHESIA;;HYPERPYREXIA, MALIGNANT; MHKING SYNDROME, INCLUDED;;KING-DENBOROUGH SYNDROME, INCLUDED	RYR1	6261
0.6499	1.6812	OMIM:189700	%189700 TORUS PALATINUS AND TORUS MANDIBULARIS		
0.6499	1.6754	OMIM:615330	#615330 MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	IBA57, VTI1A	200205, 143187
0.6499	1.6591	OMIM:212080	CARDIAC LIPIDOSIS, FAMILIAL		
0.6499	1.6521	OMIM:608864	OROFACIAL CLEFT 6	IRF6	3664
0.6499	1.6521	OMIM:119530	%119530 OROFACIAL CLEFT 1; OFC1;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 1;;OROFACIAL CLEFT, NONSYNDROMIC; OFC;;CLEFT LIP/PALATE, NONSYNDROMIC		
0.6499	1.6521	OMIM:608874	#608874 OROFACIAL CLEFT 5; OFC5;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 5	MSX1	4487
0.6499	1.6291	OMIM:236795	%236795 3-@HYDROXYISOBUTYRIC ACIDURIA		
0.6499	1.6256	OMIM:600462	#600462 MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1;;MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	PUS1	80324
0.6499	1.6056	OMIM:600625	OROFACIAL CLEFT 11 CLEFT LIP, CONGENITAL HEALED, INCLUDED CONGENITAL HEALED CLEFT LIP, INCLUDED	BMP4	652
0.6499	1.5896	OMIM:614654	#614654 COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	COQ9	57017
0.6499	1.5804	OMIM:138040	GLUCOCORTICOID RECEPTOR	NR3C1	2908
0.6499	1.5670	OMIM:615440	#615440 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17; COXPD17	ELAC2	60528
0.6499	1.5227	OMIM:610678	#610678 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	TUFM	7284
